Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL

View/Open

Supporting information (63.31Kb)

Publication Date

2017-05-11

ICR Author

Marsden,

Author

Barr, PM

Brown, JR

Hillmen, P

O'Brien, S

Barrientos, JC

Reddy, NM

Coutre, S

Mulligan, SP

Jaeger, U

Furman, RR

Cymbalista, F

Montillo, M

Dearden, C

Robak, T

Moreno, C

Pagel, JM

Burger, JA

Suzuki, S

Sukbuntherng, J

Cole, G

James, DF

Byrd, JC

Type

Journal Article

Metadata

Show full item record

URL

https://repository.icr.ac.uk/handle/internal/1544

Collections

• Other ICR Research

Version of record

10.1182/blood-2016-12-737346

Language

en

License start date

2017-05-11

Citation

Blood, 2017, 129 (19), pp. 2612 - 2615

Publisher

American Society of Hematology